Latest Drug Approvals news
Eli Lilly to Buy Gene Therapy Firm Verve in $1 Billion Deal to Develop Heart Drug
posted June 18th
by modernClinician Editorial Team
by modernClinician Editorial Team
FDA Offers Speedier Approvals to Drug Companies Aligning With “National Priorities”
posted June 18th
by modernClinician Editorial Team
by modernClinician Editorial Team
Agency is offering vouchers to some drug manufacturers to shorten review time for final drug applications
Texas Invests $50M in Psychedelic Drug Research to Treat Addiction
posted June 16th
by modernClinician Editorial Team
by modernClinician Editorial Team
Editor's Recommendations
Onset of Mortality, Morbidity Delayed for Offspring of Centenarians 
Antenatal Complications Increased With Maternal Multiple Long-Term Conditions 
Phthalates From Personal Care Products Tied to Higher BP in Pregnancy 
Vascular Burden in Midlife Linked to Increased Risk for Dementia, Death Related Articles
Countries Involved in U.S. Clinical Trials Do Not Gain Timely Access to Approved Medicines 
FDA Picks George Tidmarsh to Head Center for Drug Evaluation and Research 
Approved-Label Populations for New Drugs Broader Than Trial Populations Monthly Specialist Briefings
Stay Connected
